CureApp Hypertension Therapeutics App: Clinical Trial Results Announced At ESC Congress 2021 And Published In The European Heart Journal, A Leading Cardiovascular Journal
TOKYO–(BUSINESS WIRE)–The results of a Japanese Phase III domestic multicenter randomized controlled trial of a digital therapeutic app for hypertension (DTx) jointly developed by CureApp, Inc. (CEO Kohta Satake; hereafter…